Fast-Track Aspirin Odyssey: ICU Chronicles

Malay Rathod1, Shivani Modi2, Sai Gaddameedi1

  • 1Internal Medicine, Monmouth Medical Center, Rutgers University, Long Branch, USA.

Cureus
|October 29, 2024
PubMed

Insights

Rapid aspirin desensitization enables crucial post-stent treatment for patients with aspirin hypersensitivity. This approach facilitates necessary procedures like percutaneous coronary intervention (PCI) and stent placement in critical coronary artery disease cases.

Area of Science:

  • Cardiology
  • Allergology
  • Pharmacology

Background:

  • Aspirin is vital for managing coronary artery disease (CAD), particularly after procedures like percutaneous coronary intervention (PCI) and stent placement.
  • Aspirin hypersensitivity presents a clinical challenge, necessitating alternative treatments like clopidogrel or desensitization protocols.
  • Traditional aspirin desensitization protocols can be lengthy and impractical in emergent situations requiring immediate intervention.

Observation:

  • A patient with coronary artery stenosis requiring stent placement reported a severe aspirin allergy.
  • Standard aspirin desensitization protocols were deemed impractical due to the emergent nature of the condition.
  • A rapid aspirin desensitization protocol was successfully administered in the Intensive Care Unit (ICU) within a short timeframe.

Findings:

  • The rapid desensitization allowed the patient to undergo PCI and subsequent stent placement in the right coronary artery (RCA).
  • The patient tolerated dual antiplatelet therapy (DAPT) with aspirin and clopidogrel post-procedure.
  • Successful rapid desensitization enabled essential treatment for CAD in an aspirin-allergic patient.

Implications:

  • Rapid aspirin desensitization offers a viable and time-efficient alternative for managing aspirin-allergic patients needing urgent cardiovascular interventions.
  • This approach expands treatment options for patients with CAD and aspirin hypersensitivity, improving outcomes.
  • Facilitates adherence to long-term aspirin therapy post-stent placement, crucial for preventing stent thrombosis.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
3
Acute Coronary SyndromeI: Introduction01:30

Acute Coronary SyndromeI: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
3
Acute Coronary Syndrome III: Diagnostic studies01:30

Acute Coronary Syndrome III: Diagnostic studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
478
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1
Coronary Artery Disease V: Surgical Management01:27

Coronary Artery Disease V: Surgical Management

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3